Nombre del producto:methyl 4-(hydroxymethyl)picolinate

IUPAC Name:methyl 4-(hydroxymethyl)pyridine-2-carboxylate

CAS:317335-15-2
Fórmula molecular:C8H9NO3
Pureza:97%
Número de catálogo:CM178754
Peso molecular:167.16

Unidad de embalaje Stock disponible Precio($) Cantidad
CM178754-50g in stock ĽĽźư

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :317335-15-2
Fórmula molecular:C8H9NO3
Punto de fusión:-
Código de sonrisas:O=C(OC)C1=NC=CC(CO)=C1
Densidad:
Número de catálogo:CM178754
Peso molecular:167.16
Punto de ebullición:
Nº Mdl:MFCD09834350
Almacenamiento:Store at room temperature.

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

BMF-219
Biomea Fusion’s BMF-219 demonstrates promising early signs of clinical activity, with its ability to achieve durable and sustained complete responses (CRs) and minimal residual disease negativity (MRD-neg) in patients with acute myeloid leukemia (AML). Biomea Fusion recently presents this First Complete Responder from Ongoing Phase I Study at the 2023 ASH.
BMF-219 is the first and only covalent menin inhibitor in clinical development for AML, ALL, DLBCL, MM and CLL. Additionally, BMF-219 is being explored for its potential to regenerate insulin-producing beta cells as a treatment of type 1 diabetes.